TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration
Keyword(s):
2020 ◽
Vol 125
◽
pp. 109994
◽
Keyword(s):
2018 ◽
Vol 14
(1)
◽
pp. 35-40
◽
2000 ◽
Vol 153
(5)
◽
pp. 725-728
◽
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽